Novartis CEO: We Need a Different Approach to Drug Discovery

Regulators should consider evolving their policies and guidelines to enable them to more fully reflect on the merits of such findings when making key decisions and establishing product labeling, similar to emerging regulatory guidance on the use of real-world evidence. This could mean accepting data ...

from Google Alert - decision making

Leave a Reply